报价延迟最少15分钟:2026/06/06 00:15 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
28.1 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.09/-0.21
|
|
企业价值
2.50B
|
| 资产负债 |
|
每股账面净值
3.31
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
176.03M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis. |
